Autoimmune pancreatitis – the special form of chronic pancreatitis
Abstract
The aim of review. To present features of clinical presentation, diagnostics and treatment of special form of chronic pancreatitis – autoimmune pancreatitis (AIP).
Key points. The etiology of AIP is investigated insufficiently, the role of infection (in particular, viral), antigenic damage of pancreatic ducts and acinar cells is considered. AIP is frequently combined to other autoimmune diseases. The most typical serological marker of AIP is elevation of serum IgG4 level. Now 2 types of AIP are defined. AIP of the second type requires mandatory morphological confirmation. AIP is characterized by good treatment response by corticosteroids.
Conclusion. The issue of AIP remains actual and requires further studies.
About the Author
Ya. S. Tsimmerman
State educational state-funded institution of higher professional education «Wagner Perm state medical academy», Ministry of Healthcare of the Russian Federation
Russian Federation
Russian Federation
Tsimmerman Yacob S. – Honored scientist of the Russian Federation, MD, PhD, professor of chair of faculty therapy
614990, Perm, Kuybyshev street, 39
References
1. Васильев ЮВ. Аутоиммунный панкреатит. Экспер клин гастроэнтерол, 2005; 2:83–6.
2. Губергриц НБ. Новости американской и японской панкреатологии (Материалы объединенной встречи Американской и Японской Ассоциации панкреатологов. – Гонолулу, ноябрь 2009). Вестн клуба панкреатол, 2010; 1:6–9.
3. Губергриц НБ. Новости мировой панкреатологии (Материалы объединенной встречи Международной Ассоциации панкреатологов и Японского панкреатологического общества – Фукуока, июль 2010). Вестн клуба панкреатол, 2010; 4:6–13.
4. Егоров ВИ, Вишневсий ВА, Кармазановский ГГ. и др. Аутоиммунный панкреатит: оперировать или нет? Consilium medicum. Прил.: Гастроэнтерология, 2008; 1:14–9.
5. Маев ИВ, Кучерявый ЮА, Оганесян ТС. Аутоиммунный панкреатит: Учебное пособие. – М., 2011.
6. Маев ИВ, Кучерявый ЮА. Аутоиммунный панкреатит. Рос журн гастроэнтерол гепатол колопроктол, 2004; 6:47–55.
7. Циммерман ЯС. Helicobacter pylori-инфекция: внежелудочные эффекты и заболевания (критический анализ). Клин мед, 2006; 4:63–7.
8. Циммерман ЯС. «Маастрихтский консенсус-4» (2011): основные положения и комментарии к ним. Клин мед, 2012; 9:28–34.
9. Циммерман ЯС. Хронический панкреатит/ В кн.: ЯС. Циммерман: Гастроэнтерология. – М., 2012:415–44.
10. Aoki S, Nakazawa T, Ohara H, et al. Immunohistochemical study of autoimmune pancreatitis using anti-IgG4-antibody and patients sera. Histopathology, 2005; 47:147–58.
11. Aparisi L, Farre A, Gomez-Cambronero L, et al. Antibodies to carbonic anhydrase and IgG4 level in idiopathic chronic pancreatitis. Relevance for diagnosis of autoimmune pancreatitis. Gut, 2005; 54:703–9.
12. Bhardway P, Sarg PK, Maulik SK, et al. A randomized controlled trial of antioxidant supplemention for pain relief in patient with chronic pancreatitis. Gastroenterology, 2009; 136 (1):325–33.
13. Chari ST, Kloppel G, Zhang L, et al. The autoimmune pancreatitis International cooperative study group (APICS). Histopathologic and clinical subtypes of autoimmune pancreatitis: The Honolulu consensus document/ Pancreas, 2010; 39:549–54.
14. Chari ST, Smyrk TC, Levy MJ, et al. Diagnosis of autoimmune pancreatitis: The Mayo Clinic Experience. Clin Gastroenterol, Hepatol, 2006; 4:1010–6.
15. Chari ST, Takahashi N, Levy MJ, et al. A diagnostic strategy to distinguish autoimmune pancreatitis from pancreatic cancer. Clin Gastroenterol, Hepatol, 2009; 7:1097–103.
16. Etamad B, Whitcomb DC. Chronic pancreatitis: Diagnosis, classification, and new genetic developments. Gastrpenterology, 2001; 120:682–707.
17. Fukui T, Okazaki K, Yochizawa H, et al. A case of autoimmune pancreatitis, associated with sclerosing cholangitis, retroperitoneal fibrosis and Sjogren`s syndrome. Pancreatology, 2005; 5; 86–91.
18. Fukukura Y, Fujiyochi F, Nakamara F, et al. Autoimmune pancreatitis associated with idiopathic retroperitoneal fibrosis. Am J Roentgenol. 2003; 181:993–5.
19. Furukawa N, Muranaka T, Yasumory K, et al. Autoimmune pancreatitis: Radiologic findings in three
20. Histologically proven cases. J Comput Assist Tomogr, 1998; 22:880–3.
21. Hahm K, Im Y, Lee C, et al. Loss of TGF-signaling contributes to autoimmune pancreatitis. J Clin Invest, 2000; 105:1057–65.
22. Hong SP, Park SW, Chung JP, et al. Autoimmune pancreatitis with effective steroid therapy. Yonsey Med J, 2003; 44 (3):534–8.
23. Horiuchi A, Kaneko T, Yamamura N, et al. Autoimmune chronic pancreatitis simulating pancreatic lymphoma. Am J Gastroenterol, 1996; 91; 2607–9.
24. Horiuchi A, Kawa S, Akamatsu T, et al. Characteristic pancreatic duct appearance in autoimmune chronic pancreatitis: A case report and review of the Japanese literature. Am J Gastroenterol, 1998; 93:260–3.
25. Ito T, Nakano I, Koyanagi S, et al. Autoimmune pancreatitis as a new clinical entity: Three cases of autoimmune pancreatitis with effective steroid therapy. Dig Dis Sci, 1997; 42:1458–68.
26. Kamisawa T, Matsukawa M, Ohkawa M. Autoimmune pancreatitis associated with retroperitoneal fibrosis. JOP J Pancreas (Online), 2005; 6 (3):260–3.
27. Kamisawa T, Tu Y, Egawa N, et al. Involvement of pancreatic and bile ducts in autoimmune pancreatitis. World J Gastroenterol, 2006; 12 (4):612–4.
28. Kamisawa T, Yoshike M, Egawa N, et al. Treating patients with autoimmune pancreatitis: Results from a long –term fallow-up study. Pancreatology, 2005; 5:234–8.
29. Kim KP, Kim MU, Song MH, et al. Autoimmune chronic pancreatitis. Am J Gastroenterol,2004; 99:1605–16.
30. Kloppel G, Detiefsen S, Chari ST, et al. Autoimmune pancreatitis: The clinicopathological characteristics of the subtype with granulocytic epithelial lesions. J Gastroenterol, 2010; 45:787–93.
31. Kojirna E, Kimura K, Noda Y, et al. Autoimmune pancreatitis and multiple bile duct strictures treated effectively with steroid. J Gastroenterol, 2003; 38:303–7.
32. Lohr JM, Faissner R, Koczan D, et al. Autoantibodies against the exocrine pancreas in autoimmune pancreatitis: Gene and protein expression profiling and immunoassays inenfiti pancreatic enzymes as a major target of the inflammatory process. Am J Gastroenterol, 2010; 105:2060–71.
33. Moon S-H, Kim MH, Park DH, et al. Is a 2-week steroid trial after initial negative intestigation for malignancy use ful in differentiating autoimmune pancreatitis from pancreatic cancers? – A prospective autcome study. Gut, 2008; 57:1704–12.
34. Nishimori I, Tomakoshi A, Olsuki MJ. Prevalence of autoimmune pancreatitis in Japan from a nationwide survey in 2002. Gastroenterology, 2007, 42 (suppl 18):6–8.
35. Okazaki K, Uchida K, Ohana M, et al. Autoimmunerelated pancreatitis is associated with autoantibodies and a Th1/Th2 – type cellular immune response. Gastroenterology, 2000; 118:573–81.
36. Otsuki M, Chung JB, Okazaki K, et al. Asian diagnostic criterica for autoimmune pancreatitis: Consensus of the Japan-Korea Symposium on Autoimmune Pancreatitis. J Gastroenterol, 2008; 43:403–8.
37. Ozsvar Z, Deak J, Pap A. Possible role of Coxsackie B virus infection in pancreatitis. Int J Pancreatol, 1992, 11:105–8.
38. Sarles H, Sarles Y, Muratore R, et al. Chronic inflammatory sclerosis of the pancreas – an autonomus pancreatic disease? Am J Dig Dis, 1961; 6:688–99.
39. Shimosegawa T, Chari ST, Frulloni L, et al. International consensus diagnostic criteria for autoimmune pancreatitis. Pancreas, 2011; 40:352–8.
40. Taniguchi T, Seko S, Azuma K, et al. Autoimmune pancreatitis detected as a mass in the trial of the pancreas. J Gastroenterol Hepatol, 2000; 15:461–4.
41. Tsubakio K, Kiriyama K, Matsushima N, et al. Autoimmune pancreatitis succusful bu treated with ursodeoxycholic acid. Intern Med, 2002; 41 (12):1142–6.
42. Uchida K, Okazaki K, Konichi Y, et al. Clinical analysis of autoimmune-related pancreatitis. Am J Gastrjenterol, 2000; 95:2788–94.
43. Van Biervliet S, de Waele K, van Winckel M, Roberecht E. Transient exocrine pancreatic insufficiency as a possible complication of a enterovirus infection. Eur J Pediatr, 2003; 162 (12):872–4.
44. Wakabayashi T, Motoo Y, Kojima Y, et al. Chronic pancreatitis with diffuse irregular narrowing of the main pancreatic duct. Dig Dis Sci, 1998; 43:2415–25.
45. Yoshida K, Toni F, Takeuchi T, et al. Chronic pancreatitis caused by an autoimmune abnormality proposal of the concept of autoimmune pancreatitis. Dig Dis Sci, 1995; 40:1561–8.
46. Zamboni G, Luttges J, Capelli P, et al. Histopathologic features of diagnostic and clinical relevance in autoimmune pancreatitis: A study 53 resection specimes and 9 biopsy specimes. Virchow`s Arch, 2004; 445:552–3.
Review
For citations:
Tsimmerman Ya.S. Autoimmune pancreatitis – the special form of chronic pancreatitis. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2013;23(3):9-15. (In Russ.)
Views:
109
Email this article 
